HCPCS Level II
J9334
Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
Codes near J9334
These sit next to J9334 in the CMS Level II file. All J codes
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9331Injection, sirolimus protein-bound particles, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
- J9333Injection, rozanolixizumab-noli, 1 mg
- J9340Injection, thiotepa, 15 mg
- J9341Injection, thiotepa (tepylute), 1 mg
- J9342Injection, thiotepa, not otherwise specified, 1 mg
- J9345Injection, retifanlimab-dlwr, 1 mg
- J9347Injection, tremelimumab-actl, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 73475-1221-01 | Vyvgart Hytrulo | Argenx US, Inc | 500 |
| 73475-1221-04 | Vyvgart Hytrulo | Argenx US, Inc | 2000 |
| 73475-3102-03 | Vyvgart Hytrulo | Argenx US, Inc | 504 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.